Context Therapeutics Inc.
CNTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001842952
No open-market purchases or sales by Context Therapeutics Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $34.8M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Context Therapeutics Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +1 vs. Q4 2023
- Shares held
- 3.94M
- +376.5K (+10.6%) vs. Q4 2023
- Total value
- $5.43M
- +$1.41M (+35.1%) vs. Q4 2023
- New holders
- 4
- 6 more added
- Sold out
- 3
- 2 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 79 | $34.8M |
| Q1 2026 | 60 | $194.6M |
| Q4 2025 | 43 | $96.0M |
| Q3 2025 | 37 | $66.8M |
| Q2 2025 | 39 | $45.0M |
| Q1 2025 | 42 | $43.7M |
| Q4 2024 | 52 | $76.4M |
| Q3 2024 | 42 | $111.2M |
| Q2 2024 | 34 | $114.3M |
| Q1 2024 | 25 | $5.43M |
| Q4 2023 | 24 | $4.02M |
| Q3 2023 | 23 | $3.89M |
| Q2 2023 | 22 | $3.58M |
| Q1 2023 | 22 | $722.6K |
| Q4 2022 | 24 | $2.55M |
| Q3 2022 | 24 | $4.59M |
| Q2 2022 | 20 | $6.32M |
| Q1 2022 | 16 | $6.30M |
| Q4 2021 | 19 | $9.44M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Context Therapeutics Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 1,108,357 | $1.53M | 0.33% | +133,357+13.7% | Added |
| Ally Bridge Group (NY) LLC | 725,951 | $1.00M | 0.56% | 00.0% | Unchanged |
| Vanguard Group Inc | 598,303 | $825.7K | 0.00% | +2,291+0.4% | Added |
| Affinity Asset Advisors, LLC | 328,817 | $453.8K | 0.07% | 00.0% | Unchanged |
| UBS Oconnor LLC | 296,675 | $409.4K | 0.01% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 205,934 | $284.2K | 0.08% | +205,934 | New |
| HighTower Advisors, LLC | 125,852 | $174.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 105,809 | $146.0K | 0.00% | 00.0% | Unchanged |
| Mill Creek Capital Advisors, LLC | 104,631 | $144.4K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 101,072 | $139.5K | 0.00% | +3,832+3.9% | Added |
| Renaissance Technologies LLC | 39,900 | $55.0K | 0.00% | +7,700+23.9% | Added |
| Northern Trust Corp | 37,219 | $51.4K | 0.00% | 00.0% | Unchanged |
| Clear Harbor Asset Management, LLC | 36,000 | $49.7K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 32,907 | $45.4K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 22,389 | $30.9K | 0.00% | +22,389 | New |
| Sheets Smith Wealth Management | 20,000 | $27.6K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 15,041 | $20.8K | 0.00% | −839−5.3% | Reduced |
| Jefferies Financial Group Inc. | 11,453 | $15.8K | 0.00% | +11,453 | New |
| XTX Topco Ltd | 10,261 | $14.2K | 0.00% | +10,261 | New |
| Tower Research Capital LLC (TRC) | 6,357 | $8.77K | 0.00% | −298−4.5% | Reduced |
| Advisor Group Holdings, Inc. | 1,500 | $2.07K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 400 | $552 | 0.00% | 00.0% | Unchanged |
| Retirement Group, LLC | 155 | $214 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 116 | $160 | 0.00% | +2+1.8% | Added |
| JPMorgan Chase & Co | 33 | $46 | 0.00% | +10+43.5% | Added |
| Aspire Wealth Management Corp | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −9,490−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −109−100.0% | Sold out |